Clinical Trial Update: iTBS Study for Depression (Randomized) [NA]

View source ↗

Summary

A completed randomized trial evaluating iTBS for depression and executive dysfunction with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Executive Dysfunction
• Major Depressive Disorder

Snippet

Sponsor: Washington University School of Medicine | Conditions: Executive Dysfunction, Depression | NA | Status: COMPLETED | Results posted: 2022-07-06